Enoxacin

依诺沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameEnoxacin
Drug Alias Name依若沙星Enoxacinum伊诺沙星Enoxacino氟啶酸 +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsAmyotrophic Lateral SclerosisBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1991/01/01
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesMcGill UniversityGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsAmyotrophic Lateral SclerosisBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01MA04
Related LinksWikipediaDrugBankKEGG